HUTCHMED provides full year 2025 guidance for Oncology/Immunology consolidated revenue of $350 million to $450 million. HUTCHMED's work in 2025 and beyond will be supported by its strong balance sheet ...

This year, the Iditarod saw both a historic anniversary and the marked impact of climate change. Writer Lale Arikoglu follows ...